-
1
-
-
0028120805
-
Fludarabine phosphate: A new active agent in hematologic malignancies
-
M.J. Keating, S. O'Brien, W. Plunkett, L.E. Robertson, V. Gandhi, and E. Estey Fludarabine phosphate: a new active agent in hematologic malignancies Semin Hematol 31 1 1994 28 39
-
(1994)
Semin Hematol
, vol.31
, Issue.1
, pp. 28-39
-
-
Keating, M.J.1
O'Brien, S.2
Plunkett, W.3
Robertson, L.E.4
Gandhi, V.5
Estey, E.6
-
2
-
-
0038509118
-
Mechanism of action of purine analogues in chronic lymphocytic leukaemia
-
A.R. Pettitt Mechanism of action of purine analogues in chronic lymphocytic leukaemia Br J Haematol 121 5 2003 692 702
-
(2003)
Br J Haematol
, vol.121
, Issue.5
, pp. 692-702
-
-
Pettitt, A.R.1
-
3
-
-
0036125593
-
The role of nucleoside analogues in the treatment of chronic lymphocytic leukemia-lessons learned from prospective randomized trials
-
T. Robak The role of nucleoside analogues in the treatment of chronic lymphocytic leukemia-lessons learned from prospective randomized trials Leuk Lymphoma 43 3 2002 537 548
-
(2002)
Leuk Lymphoma
, vol.43
, Issue.3
, pp. 537-548
-
-
Robak, T.1
-
4
-
-
0036179221
-
Oral cladribine for B-cell chronic lymphocytic leukaemia: Report of a phase II trial with a 3-d, 3-weekly schedule in untreated and pretreated patients, and a long-term follow-up of 126 previously untreated patients
-
K. Karlsson, M. Stromberg, J. Liliemark, A. Delannoy, S.A. Johnson, and A. Porwit Oral cladribine for B-cell chronic lymphocytic leukaemia: report of a phase II trial with a 3-d, 3-weekly schedule in untreated and pretreated patients, and a long-term follow-up of 126 previously untreated patients Br J Haematol 116 3 2002 538 548
-
(2002)
Br J Haematol
, vol.116
, Issue.3
, pp. 538-548
-
-
Karlsson, K.1
Stromberg, M.2
Liliemark, J.3
Delannoy, A.4
Johnson, S.A.5
Porwit, A.6
-
5
-
-
0025890427
-
Metabolism and action of purine nucleoside analogs
-
W. Plunkett, and P.P. Saunders Metabolism and action of purine nucleoside analogs Pharmacol Ther 49 3 1991 239 268
-
(1991)
Pharmacol Ther
, vol.49
, Issue.3
, pp. 239-268
-
-
Plunkett, W.1
Saunders, P.P.2
-
6
-
-
0242560897
-
Substrate specificity of human recombinant mitochondrial deoxyguanosine kinase with cytostatic and antiviral purine and pyrimidine analogs
-
A.H. Sjoberg, L. Wang, and S. Eriksson Substrate specificity of human recombinant mitochondrial deoxyguanosine kinase with cytostatic and antiviral purine and pyrimidine analogs Mol Pharmacol 53 2 1998 270 273
-
(1998)
Mol Pharmacol
, vol.53
, Issue.2
, pp. 270-273
-
-
Sjoberg, A.H.1
Wang, L.2
Eriksson, S.3
-
7
-
-
0037441388
-
Selective activation of deoxycytidine kinase by thymidine-5′- thiosulphate and release by deoxycytidine in human lymphocytes
-
G. Keszler, K. Szikla, Z. Kazimierczuk, T. Spasokoukotskaja, M. Sasvari-Szekely, and M. Staub Selective activation of deoxycytidine kinase by thymidine-5′-thiosulphate and release by deoxycytidine in human lymphocytes Biochem Pharmacol 65 4 2003 563 571
-
(2003)
Biochem Pharmacol
, vol.65
, Issue.4
, pp. 563-571
-
-
Keszler, G.1
Szikla, K.2
Kazimierczuk, Z.3
Spasokoukotskaja, T.4
Sasvari-Szekely, M.5
Staub, M.6
-
8
-
-
1042275536
-
Activation of deoxycytidine kinase in lymphocytes is calcium dependent and involves a conformational change detectable by native immunostaining
-
G. Keszler, T. Spasokoukotskaja, Z. Csapo, I. Talianidis, S. Eriksson, and M. Staub Activation of deoxycytidine kinase in lymphocytes is calcium dependent and involves a conformational change detectable by native immunostaining Biochem Pharmacol 67 5 2004 947 955
-
(2004)
Biochem Pharmacol
, vol.67
, Issue.5
, pp. 947-955
-
-
Keszler, G.1
Spasokoukotskaja, T.2
Csapo, Z.3
Talianidis, I.4
Eriksson, S.5
Staub, M.6
-
9
-
-
0344973660
-
Activation of deoxycytidine kinase during inhibition of DNA synthesis by 2-chloro-2′-deoxyadenosine (cladribine) in human lymphocytes
-
M. Sasvari-Szekely, T. Spasokoukotskaja, M. Szoke, Z. Csapo, A. Turi, and I. Szanto Activation of deoxycytidine kinase during inhibition of DNA synthesis by 2-chloro-2′-deoxyadenosine (cladribine) in human lymphocytes Biochem Pharmacol 56 9 1998 1175 1179
-
(1998)
Biochem Pharmacol
, vol.56
, Issue.9
, pp. 1175-1179
-
-
Sasvari-Szekely, M.1
Spasokoukotskaja, T.2
Szoke, M.3
Csapo, Z.4
Turi, A.5
Szanto, I.6
-
10
-
-
0031836864
-
Activation of deoxycytidine kinase by various nucleoside analogues
-
T. Spasokoukotskaja, M. Sasvari-Szekely, L. Hullan, F. Albertioni, S. Eriksson, and M. Staub Activation of deoxycytidine kinase by various nucleoside analogues Adv Exp Med Biol 431 1998 641 645
-
(1998)
Adv Exp Med Biol
, vol.431
, pp. 641-645
-
-
Spasokoukotskaja, T.1
Sasvari-Szekely, M.2
Hullan, L.3
Albertioni, F.4
Eriksson, S.5
Staub, M.6
-
11
-
-
0032531671
-
Phosphorylation of anticancer nucleoside analogs by human mitochondrial deoxyguanosine kinase
-
C. Zhu, M. Johansson, J. Permert, and A. Karlsson Phosphorylation of anticancer nucleoside analogs by human mitochondrial deoxyguanosine kinase Biochem Pharmacol 56 8 1998 1035 1040
-
(1998)
Biochem Pharmacol
, vol.56
, Issue.8
, pp. 1035-1040
-
-
Zhu, C.1
Johansson, M.2
Permert, J.3
Karlsson, A.4
-
12
-
-
0036076401
-
Low level of mitochondrial deoxyguanosine kinase is the dominant factor in acquired resistance to 9-beta-d-arabinofuranosylguanine cytotoxicity
-
K. Lotfi, E. Mansson, C. Peterson, S. Eriksson, and F. Albertioni Low level of mitochondrial deoxyguanosine kinase is the dominant factor in acquired resistance to 9-beta-d-arabinofuranosylguanine cytotoxicity Biochem Biophys Res Commun 293 5 2002 1489 1496
-
(2002)
Biochem Biophys Res Commun
, vol.293
, Issue.5
, pp. 1489-1496
-
-
Lotfi, K.1
Mansson, E.2
Peterson, C.3
Eriksson, S.4
Albertioni, F.5
-
13
-
-
0034767094
-
Semiquantitative reverse transcription-polymerase chain reaction with the Agilent 2100 Bioanalyzer
-
E. Gottwald, O. Muller, and A. Polten Semiquantitative reverse transcription-polymerase chain reaction with the Agilent 2100 Bioanalyzer Electrophoresis 22 18 2001 4016 4022
-
(2001)
Electrophoresis
, vol.22
, Issue.18
, pp. 4016-4022
-
-
Gottwald, E.1
Muller, O.2
Polten, A.3
-
14
-
-
0036122781
-
Real-time quantitative PCR assays for deoxycytidine kinase, deoxyguanosine kinase and 5′-nucleotidase mRNA measurement in cell lines and in patients with leukemia
-
E. Mansson, E. Liliemark, S. Soderhall, G. Gustafsson, S. Eriksson, and F. Albertioni Real-time quantitative PCR assays for deoxycytidine kinase, deoxyguanosine kinase and 5′-nucleotidase mRNA measurement in cell lines and in patients with leukemia Leukemia 16 3 2002 386 392
-
(2002)
Leukemia
, vol.16
, Issue.3
, pp. 386-392
-
-
Mansson, E.1
Liliemark, E.2
Soderhall, S.3
Gustafsson, G.4
Eriksson, S.5
Albertioni, F.6
-
15
-
-
0034663307
-
High incidence of alternatively spliced forms of deoxycytidine kinase in patients with resistant acute myeloid leukemia
-
M.J. Veuger, M.W. Honders, J.E. Landegent, R. Willemze, and R.M. Barge High incidence of alternatively spliced forms of deoxycytidine kinase in patients with resistant acute myeloid leukemia Blood 96 4 2000 1517 1524
-
(2000)
Blood
, vol.96
, Issue.4
, pp. 1517-1524
-
-
Veuger, M.J.1
Honders, M.W.2
Landegent, J.E.3
Willemze, R.4
Barge, R.M.5
-
16
-
-
0032724360
-
Rapid and sensitive minimal residual disease detection in acute leukemia by quantitative real-time RT-PCR exemplified by t(12;21) TEL-AML1 fusion transcript
-
N. Pallisgaard, N. Clausen, H. Schroder, and P. Hokland Rapid and sensitive minimal residual disease detection in acute leukemia by quantitative real-time RT-PCR exemplified by t(12;21) TEL-AML1 fusion transcript Genes Chromosomes Cancer 26 4 1999 355 365
-
(1999)
Genes Chromosomes Cancer
, vol.26
, Issue.4
, pp. 355-365
-
-
Pallisgaard, N.1
Clausen, N.2
Schroder, H.3
Hokland, P.4
-
17
-
-
0037325637
-
A phase II study of cladribine treatment for fludarabine refractory B cell chronic lymphocytic leukemia: Results from CALGB Study 9211
-
J.C. Byrd, B. Peterson, L. Piro, A. Saven, J.W. Vardiman, and R.A. Larson A phase II study of cladribine treatment for fludarabine refractory B cell chronic lymphocytic leukemia: results from CALGB Study 9211 Leukemia 17 2 2003 323 327
-
(2003)
Leukemia
, vol.17
, Issue.2
, pp. 323-327
-
-
Byrd, J.C.1
Peterson, B.2
Piro, L.3
Saven, A.4
Vardiman, J.W.5
Larson, R.A.6
-
18
-
-
0028087112
-
High incidence of infections after 2-chlorodeoxyadenosine (2-CDA) therapy in patients with malignant lymphomas and chronic and acute leukaemias
-
D.C. Betticher, M.F. Fey, A. von Rohr, A. Tobler, H. Jenzer, and A. Gratwohl High incidence of infections after 2-chlorodeoxyadenosine (2-CDA) therapy in patients with malignant lymphomas and chronic and acute leukaemias Ann Oncol 5 1 1994 57 64
-
(1994)
Ann Oncol
, vol.5
, Issue.1
, pp. 57-64
-
-
Betticher, D.C.1
Fey, M.F.2
Von Rohr, A.3
Tobler, A.4
Jenzer, H.5
Gratwohl, A.6
-
19
-
-
0026675806
-
Response to 2-chlorodeoxyadenosine in patients with B-cell chronic lymphocytic leukemia resistant to fludarabine
-
G. Juliusson, R.A. Elmhorn, and J. Liliemark Response to 2-chlorodeoxyadenosine in patients with B-cell chronic lymphocytic leukemia resistant to fludarabine N Engl J Med 327 15 1992 1056 1061 [see comments]
-
(1992)
N Engl J Med
, vol.327
, Issue.15
, pp. 1056-1061
-
-
Juliusson, G.1
Elmhorn, R.A.2
Liliemark, J.3
-
20
-
-
0030018146
-
Long-term survival following cladribine (2-chlorodeoxyadenosine) therapy in previously treated patients with chronic lymphocytic leukemia
-
G. Juliusson, and J. Liliemark Long-term survival following cladribine (2-chlorodeoxyadenosine) therapy in previously treated patients with chronic lymphocytic leukemia Ann Oncol 7 4 1996 373 379
-
(1996)
Ann Oncol
, vol.7
, Issue.4
, pp. 373-379
-
-
Juliusson, G.1
Liliemark, J.2
-
21
-
-
0033406797
-
Molecular and biochemical mechanisms of fludarabine and cladribine resistance in a human promyelocytic cell line
-
E. Mansson, T. Spasokoukotskaja, J. Sallstrom, S. Eriksson, and F. Albertioni Molecular and biochemical mechanisms of fludarabine and cladribine resistance in a human promyelocytic cell line Cancer Res 59 23 1999 5956 5963
-
(1999)
Cancer Res
, vol.59
, Issue.23
, pp. 5956-5963
-
-
Mansson, E.1
Spasokoukotskaja, T.2
Sallstrom, J.3
Eriksson, S.4
Albertioni, F.5
-
22
-
-
0037437762
-
Down-regulation of deoxycytidine kinase in human leukemic cell lines resistant to cladribine and clofarabine and increased ribonucleotide reductase activity contributes to fludarabine resistance
-
E. Mansson, E. Flordal, J. Liliemark, T. Spasokoukotskaja, H. Elford, and S. Lagercrantz Down-regulation of deoxycytidine kinase in human leukemic cell lines resistant to cladribine and clofarabine and increased ribonucleotide reductase activity contributes to fludarabine resistance Biochem Pharmacol 65 2 2003 237 247
-
(2003)
Biochem Pharmacol
, vol.65
, Issue.2
, pp. 237-247
-
-
Mansson, E.1
Flordal, E.2
Liliemark, J.3
Spasokoukotskaja, T.4
Elford, H.5
Lagercrantz, S.6
-
23
-
-
0035004335
-
Pharmacological basis for cladribine resistance in a human acute T lymphoblastic leukaemia cell line selected for resistance to etoposide
-
K. Lotfi, E. Mansson, J. Chandra, Y. Wang, D. Xu, and E. Knaust Pharmacological basis for cladribine resistance in a human acute T lymphoblastic leukaemia cell line selected for resistance to etoposide Br J Haematol 113 2 2001 339 346
-
(2001)
Br J Haematol
, vol.113
, Issue.2
, pp. 339-346
-
-
Lotfi, K.1
Mansson, E.2
Chandra, J.3
Wang, Y.4
Xu, D.5
Knaust, E.6
-
24
-
-
0028986279
-
2′-Deoxycytidine kinase deficiency is a major determinant of 2-chloro-2′-deoxyadenosine resistance in lymphoid cell lines
-
R.M. Orr, D.C. Talbot, W.G. Aherne, T.C. Fisher, P. Serafinowski, and K.R. Harrap 2′-Deoxycytidine kinase deficiency is a major determinant of 2-chloro-2′-deoxyadenosine resistance in lymphoid cell lines Clin Cancer Res 1 4 1995 391 398
-
(1995)
Clin Cancer Res
, vol.1
, Issue.4
, pp. 391-398
-
-
Orr, R.M.1
Talbot, D.C.2
Aherne, W.G.3
Fisher, T.C.4
Serafinowski, P.5
Harrap, K.R.6
-
25
-
-
0013040873
-
Common resistance mechanisms to deoxynucleoside analogues in variants of the human erythroleukaemic line K562
-
C. Dumontet, K. Fabianowska-Majewska, D. Mantincic, E. Callet Bauchu, I. Tigaud, and V. Gandhi Common resistance mechanisms to deoxynucleoside analogues in variants of the human erythroleukaemic line K562 Br J Haematol 106 1 1999 78 85
-
(1999)
Br J Haematol
, vol.106
, Issue.1
, pp. 78-85
-
-
Dumontet, C.1
Fabianowska-Majewska, K.2
Mantincic, D.3
Callet Bauchu, E.4
Tigaud, I.5
Gandhi, V.6
-
26
-
-
0031817627
-
Mechanisms responsible for resistance of sublines derived from leukemia cell lines to an antitumor agent 9-beta-d-arabinofuranosyl-2-fluoroadenine
-
L. Bai, M. Yamaguchi, M. Tatsumi, K. Kon, and M. Brautigam Mechanisms responsible for resistance of sublines derived from leukemia cell lines to an antitumor agent 9-beta-d-arabinofuranosyl-2-fluoroadenine J Cancer Res Clin Oncol 124 7 1998 367 373
-
(1998)
J Cancer Res Clin Oncol
, vol.124
, Issue.7
, pp. 367-373
-
-
Bai, L.1
Yamaguchi, M.2
Tatsumi, M.3
Kon, K.4
Brautigam, M.5
-
27
-
-
0029947983
-
Retroviral transfer of deoxycytidine kinase into tumor cell lines enhances nucleoside toxicity
-
D.M. Hapke, A.P. Stegmann, and B.S. Mitchell Retroviral transfer of deoxycytidine kinase into tumor cell lines enhances nucleoside toxicity Cancer Res 56 10 1996 2343 2347
-
(1996)
Cancer Res
, vol.56
, Issue.10
, pp. 2343-2347
-
-
Hapke, D.M.1
Stegmann, A.P.2
Mitchell, B.S.3
-
28
-
-
0016248313
-
Mechanisms of resistance of human acute leukaemia cells to cytosine arabinoside
-
M.H. Tattersall, K. Ganeshaguru, and A.V. Hoffbrand Mechanisms of resistance of human acute leukaemia cells to cytosine arabinoside Br J Haematol 27 1 1974 39 46
-
(1974)
Br J Haematol
, vol.27
, Issue.1
, pp. 39-46
-
-
Tattersall, M.H.1
Ganeshaguru, K.2
Hoffbrand, A.V.3
-
29
-
-
0027525929
-
Relationship of deoxycytidine kinase and cytoplasmic 5′- nucleotidase to the chemotherapeutic efficacy of 2-chlorodeoxyadenosine
-
H. Kawasaki, C.J. Carrera, L.D. Piro, A. Saven, T.J. Kipps, and D.A. Carson Relationship of deoxycytidine kinase and cytoplasmic 5′- nucleotidase to the chemotherapeutic efficacy of 2-chlorodeoxyadenosine Blood 81 3 1993 597 601
-
(1993)
Blood
, vol.81
, Issue.3
, pp. 597-601
-
-
Kawasaki, H.1
Carrera, C.J.2
Piro, L.D.3
Saven, A.4
Kipps, T.J.5
Carson, D.A.6
-
30
-
-
0028093655
-
Phosphorylation of 2-chlorodeoxyadenosine (CdA) in extracts of peripheral blood mononuclear cells of leukaemic patients
-
E.S. Arner, T. Spasokoukotskaja, G. Juliusson, J. Liliemark, and S. Eriksson Phosphorylation of 2-chlorodeoxyadenosine (CdA) in extracts of peripheral blood mononuclear cells of leukaemic patients Br J Haematol 87 4 1994 715 718
-
(1994)
Br J Haematol
, vol.87
, Issue.4
, pp. 715-718
-
-
Arner, E.S.1
Spasokoukotskaja, T.2
Juliusson, G.3
Liliemark, J.4
Eriksson, S.5
-
31
-
-
0030858503
-
Deoxycytidine kinase mRNA expression in childhood acute lymphoblastic leukemia
-
G. Stammler, F. Zintl, A. Sauerbrey, and M. Volm Deoxycytidine kinase mRNA expression in childhood acute lymphoblastic leukemia Anticancer Drugs 8 5 1997 517 521
-
(1997)
Anticancer Drugs
, vol.8
, Issue.5
, pp. 517-521
-
-
Stammler, G.1
Zintl, F.2
Sauerbrey, A.3
Volm, M.4
-
32
-
-
0032409839
-
Expression of deoxycytidine kinase (dCK) gene in leukemic cells in childhood: Decreased expression of dCK gene in relapsed leukemia
-
T. Kakihara, T. Fukuda, A. Tanaka, I. Emura, K. Kishi, and K. Asami Expression of deoxycytidine kinase (dCK) gene in leukemic cells in childhood: decreased expression of dCK gene in relapsed leukemia Leuk Lymphoma 31 3-4 1998 405 409
-
(1998)
Leuk Lymphoma
, vol.31
, Issue.3-4
, pp. 405-409
-
-
Kakihara, T.1
Fukuda, T.2
Tanaka, A.3
Emura, I.4
Kishi, K.5
Asami, K.6
-
33
-
-
0038007346
-
Deoxycytidine kinase and cN-II nucleotidase expression in blast cells predict survival in acute myeloid leukaemia patients treated with cytarabine
-
C.M. Galmarini, X. Thomas, K. Graham, A. El Jafaari, E. Cros, and L. Jordheim Deoxycytidine kinase and cN-II nucleotidase expression in blast cells predict survival in acute myeloid leukaemia patients treated with cytarabine Br J Haematol 122 1 2003 53 60
-
(2003)
Br J Haematol
, vol.122
, Issue.1
, pp. 53-60
-
-
Galmarini, C.M.1
Thomas, X.2
Graham, K.3
El Jafaari, A.4
Cros, E.5
Jordheim, L.6
-
34
-
-
0023187987
-
Phase II trial of 9-beta-d-arabinofuranosyl-2-fluoroadenine 5′-monophosphate in non-Hodgkin's lymphoma: Prospective comparison of response with deoxycytidine kinase activity
-
J.M. Leiby, K.M. Snider, E.H. Kraut, E.N. Metz, L. Malspeis, and M.R. Grever Phase II trial of 9-beta-d-arabinofuranosyl-2-fluoroadenine 5′-monophosphate in non-Hodgkin's lymphoma: prospective comparison of response with deoxycytidine kinase activity Cancer Res 47 10 1987 2719 2722
-
(1987)
Cancer Res
, vol.47
, Issue.10
, pp. 2719-2722
-
-
Leiby, J.M.1
Snider, K.M.2
Kraut, E.H.3
Metz, E.N.4
Malspeis, L.5
Grever, M.R.6
-
35
-
-
0031808792
-
Relationship between cladribine (CdA) plasma, intracellular CdA-5′-triphosphate (CdATP) concentration, deoxycytidine kinase (dCK), and chemotherapeutic activity in chronic lymphocytic leukemia (CLL)
-
F. Albertioni, S. Lindemalm, S. Eriksson, G. Juliusson, and J. Liliemark Relationship between cladribine (CdA) plasma, intracellular CdA-5′- triphosphate (CdATP) concentration, deoxycytidine kinase (dCK), and chemotherapeutic activity in chronic lymphocytic leukemia (CLL) Adv Exp Med Biol 431 1998 693 697
-
(1998)
Adv Exp Med Biol
, vol.431
, pp. 693-697
-
-
Albertioni, F.1
Lindemalm, S.2
Eriksson, S.3
Juliusson, G.4
Liliemark, J.5
-
36
-
-
0036757209
-
Deoxycytidine kinase expression and activity in patients with resistant versus sensitive acute myeloid leukemia
-
M.J. Veuger, M.W. Honders, R. Willemze, and R.M. Barge Deoxycytidine kinase expression and activity in patients with resistant versus sensitive acute myeloid leukemia Eur J Haematol 69 3 2002 171 178
-
(2002)
Eur J Haematol
, vol.69
, Issue.3
, pp. 171-178
-
-
Veuger, M.J.1
Honders, M.W.2
Willemze, R.3
Barge, R.M.4
-
37
-
-
2542444476
-
5-(3)-Nucleotidase mRNA levels in blast cells are a prognostic factor in acute myeloid leukemia patients treated with cytarabine
-
C.M. Galmarini, E. Cros, K. Graham, X. Thomas, J.R. Mackey, and C. Dumontet 5-(3)-Nucleotidase mRNA levels in blast cells are a prognostic factor in acute myeloid leukemia patients treated with cytarabine Haematologica 89 5 2004 617 619
-
(2004)
Haematologica
, vol.89
, Issue.5
, pp. 617-619
-
-
Galmarini, C.M.1
Cros, E.2
Graham, K.3
Thomas, X.4
MacKey, J.R.5
Dumontet, C.6
-
38
-
-
19944428546
-
Quantitative analysis of nucleoside transporter and metabolism gene expression in chronic lymphocytic leukemia (CLL): Identification of fludarabine-sensitive and -insensitive populations
-
J.R. Mackey, C.M. Galmarini, K.A. Graham, A.A. Joy, A. Delmer, and L. Dabbagh Quantitative analysis of nucleoside transporter and metabolism gene expression in chronic lymphocytic leukemia (CLL): identification of fludarabine-sensitive and -insensitive populations Blood 105 2 2005 767 774
-
(2005)
Blood
, vol.105
, Issue.2
, pp. 767-774
-
-
MacKey, J.R.1
Galmarini, C.M.2
Graham, K.A.3
Joy, A.A.4
Delmer, A.5
Dabbagh, L.6
-
39
-
-
3242680253
-
Quantitative real time PCR of deoxycytidine kinase mRNA by Light Cycler PCR in relation to enzyme activity and gemcitabine sensitivity
-
J. Sigmond, J.R. Kroep, W. Loves, G. Codacci-Pisanelli, and G.J. Peters Quantitative real time PCR of deoxycytidine kinase mRNA by Light Cycler PCR in relation to enzyme activity and gemcitabine sensitivity Cancer Lett 213 2 2004 173 179
-
(2004)
Cancer Lett
, vol.213
, Issue.2
, pp. 173-179
-
-
Sigmond, J.1
Kroep, J.R.2
Loves, W.3
Codacci-Pisanelli, G.4
Peters, G.J.5
-
40
-
-
0026637308
-
Resistance to 1-beta-d-arabinofuranosylcytosine in human T-lymphoblasts mediated by mutations within the deoxycytidine kinase gene
-
J.K. Owens, D.S. Shewach, B. Ullman, and B.S. Mitchell Resistance to 1-beta-d-arabinofuranosylcytosine in human T-lymphoblasts mediated by mutations within the deoxycytidine kinase gene Cancer Res 52 9 1992 2389 2393
-
(1992)
Cancer Res
, vol.52
, Issue.9
, pp. 2389-2393
-
-
Owens, J.K.1
Shewach, D.S.2
Ullman, B.3
Mitchell, B.S.4
-
41
-
-
0028336786
-
Structural analysis of the deoxycytidine kinase gene in patients with acute myeloid leukemia and resistance to cytosine arabinoside
-
M. Flasshove, D. Strumberg, L. Ayscue, B.S. Mitchell, C. Tirier, and W. Heit Structural analysis of the deoxycytidine kinase gene in patients with acute myeloid leukemia and resistance to cytosine arabinoside Leukemia 8 5 1994 780 785
-
(1994)
Leukemia
, vol.8
, Issue.5
, pp. 780-785
-
-
Flasshove, M.1
Strumberg, D.2
Ayscue, L.3
Mitchell, B.S.4
Tirier, C.5
Heit, W.6
-
42
-
-
0035000750
-
Absence of mutations in the deoxycytidine kinase (dCK) gene in patients with relapsed and/or refractory acute myeloid leukemia (AML)
-
M.M. van den Heuvel-Eibrink, E.A. Wiemer, M. Kuijpers, R. Pieters, and P. Sonneveld Absence of mutations in the deoxycytidine kinase (dCK) gene in patients with relapsed and/or refractory acute myeloid leukemia (AML) Leukemia 15 5 2001 855 856
-
(2001)
Leukemia
, vol.15
, Issue.5
, pp. 855-856
-
-
Van Den Heuvel-Eibrink, M.M.1
Wiemer, E.A.2
Kuijpers, M.3
Pieters, R.4
Sonneveld, P.5
-
43
-
-
0028981978
-
Multidrug resistance (Mdr1) gene expression in peripheral blasts from patients with acute leukemia only rarely increases during disease progression after combination chemotherapy
-
A. Gruber, I. Arestrom, F. Albertioni, M. Bjorkholm, C. Peterson, and S. Vitols Multidrug resistance (Mdr1) gene expression in peripheral blasts from patients with acute leukemia only rarely increases during disease progression after combination chemotherapy Leuk Lymphoma 18 5-6 1995 435 442
-
(1995)
Leuk Lymphoma
, vol.18
, Issue.5-6
, pp. 435-442
-
-
Gruber, A.1
Arestrom, I.2
Albertioni, F.3
Bjorkholm, M.4
Peterson, C.5
Vitols, S.6
-
44
-
-
0035321315
-
Discrepancies between the gene expression, protein expression, and enzymatic activity of thymidylate synthase and dihydropyrimidine dehydrogenase in human gastrointestinal cancers and adjacent normal mucosa
-
S. Miyamoto, A. Ochiai, N. Boku, A. Ohtsu, M. Tahara, and S. Yoshida Discrepancies between the gene expression, protein expression, and enzymatic activity of thymidylate synthase and dihydropyrimidine dehydrogenase in human gastrointestinal cancers and adjacent normal mucosa Int J Oncol 18 4 2001 705 713
-
(2001)
Int J Oncol
, vol.18
, Issue.4
, pp. 705-713
-
-
Miyamoto, S.1
Ochiai, A.2
Boku, N.3
Ohtsu, A.4
Tahara, M.5
Yoshida, S.6
-
45
-
-
2942735029
-
Telomerase activity level, but not hTERT mRNA and hTR level, regulates telomere length in telomerase-reconstituted primary fibroblasts
-
S.J. Swiggers, H.A. Nibbeling, A. Zeilemaker, M.A. Kuijpers, K.A. Mattern, and J.M. Zijlmans Telomerase activity level, but not hTERT mRNA and hTR level, regulates telomere length in telomerase-reconstituted primary fibroblasts Exp Cell Res 297 2 2004 434 443
-
(2004)
Exp Cell Res
, vol.297
, Issue.2
, pp. 434-443
-
-
Swiggers, S.J.1
Nibbeling, H.A.2
Zeilemaker, A.3
Kuijpers, M.A.4
Mattern, K.A.5
Zijlmans, J.M.6
-
46
-
-
0038730444
-
Activation of deoxycytidine kinase by gamma-irradiation and inactivation by hyperosmotic shock in human lymphocytes
-
Z. Csapo, G. Keszler, G. Safrany, T. Spasokoukotskaja, I. Talianidis, and M. Staub Activation of deoxycytidine kinase by gamma-irradiation and inactivation by hyperosmotic shock in human lymphocytes Biochem Pharmacol 65 12 2003 2031 2039
-
(2003)
Biochem Pharmacol
, vol.65
, Issue.12
, pp. 2031-2039
-
-
Csapo, Z.1
Keszler, G.2
Safrany, G.3
Spasokoukotskaja, T.4
Talianidis, I.5
Staub, M.6
-
47
-
-
0037441342
-
Activation of deoxycytidine kinase by UV-C-irradiation in chronic lymphocytic leukemia B-lymphocytes
-
E. Van Den Neste, C. Smal, S. Cardoen, A. Delacauw, J. Frankard, and A. Ferrant Activation of deoxycytidine kinase by UV-C-irradiation in chronic lymphocytic leukemia B-lymphocytes Biochem Pharmacol 65 4 2003 573 580
-
(2003)
Biochem Pharmacol
, vol.65
, Issue.4
, pp. 573-580
-
-
Van Den Neste, E.1
Smal, C.2
Cardoen, S.3
Delacauw, A.4
Frankard, J.5
Ferrant, A.6
-
48
-
-
2942627604
-
Activation of deoxycytidine kinase by protein kinase inhibitors and okadaic acid in leukemic cells
-
C. Smal, S. Cardoen, L. Bertrand, A. Delacauw, A. Ferrant, and G.V. Berghe Activation of deoxycytidine kinase by protein kinase inhibitors and okadaic acid in leukemic cells Biochem Pharmacol 68 1 2004 95 103
-
(2004)
Biochem Pharmacol
, vol.68
, Issue.1
, pp. 95-103
-
-
Smal, C.1
Cardoen, S.2
Bertrand, L.3
Delacauw, A.4
Ferrant, A.5
Berghe, G.V.6
|